+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Small-Molecule APIs Market Research Report by Production (Contract Manufacturing and In-house Manufacturing), Type, Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 124 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5532976
UP TO OFF until Dec 31st 2022
The United States Small-Molecule APIs Market size was estimated at USD 4,273.42 million in 2021, USD 4,643.39 million in 2022, and is projected to grow at a CAGR 10.66% to reach USD 7,849.49 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Small-Molecule APIs to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Production, the market was studied across Contract Manufacturing and In-house Manufacturing.
  • Based on Type, the market was studied across Biological and Synthetic.
  • Based on Application, the market was studied across Cardiovascular, Diabetes, Immunological Disorders, and Oncology.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Small-Molecule APIs market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Small-Molecule APIs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Small-Molecule APIs Market, including AbbVie Inc., Albemarle Corporation, Aspen Group, Aurobindo Pharma Limited, Bachem Holding AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Cambrex Corporation by Permira funds, Carlyle Group, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche Ltd,, Gilead Sciences, Inc, GlaxoSmithKline PLC, Janssen Global Services, LLC (Johnson & Johnson Inc.), Johnson Matthey, Koninklijke DSM N.V., Lonza Group AG, Novartis AG, PCAS SA, Pfizer Inc, Sanofi S.A., Siegfried AG, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Limited.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Small-Molecule APIs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Small-Molecule APIs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Small-Molecule APIs Market?
4. What is the competitive strategic window for opportunities in the United States Small-Molecule APIs Market?
5. What are the technology trends and regulatory frameworks in the United States Small-Molecule APIs Market?
6. What is the market share of the leading vendors in the United States Small-Molecule APIs Market?
7. What modes and strategic moves are considered suitable for entering the United States Small-Molecule APIs Market?
Frequently Asked Questions about the U.S. Small-Molecule APIs Market

What is the estimated value of the U.S. Small-Molecule APIs Market?

The U.S. Small-Molecule APIs Market was estimated to be valued at $4273.42 Million in 2021.

What is the growth rate of the U.S. Small-Molecule APIs Market?

The growth rate of the U.S. Small-Molecule APIs Market is 10.6%, with an estimated value of $7849.49 Million by 2027.

What is the forecasted size of the U.S. Small-Molecule APIs Market?

The U.S. Small-Molecule APIs Market is estimated to be worth $7849.49 Million by 2027.

Who are the key companies in the U.S. Small-Molecule APIs Market?

Key companies in the U.S. Small-Molecule APIs Market include AbbVie Inc., Albemarle Corporation, Aspen Group, Aurobindo Pharma Limited, Bachem Holding AG, Boehringer Ingelheim GmbH, Bristol, Myers Squibb and Carlyle Group.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Small-Molecule Apis Market, by Production
6.1. Introduction
6.2. Contract Manufacturing
6.3. In-House Manufacturing
7. Small-Molecule Apis Market, by Type
7.1. Introduction
7.2. Biological
7.3. Synthetic
8. Small-Molecule Apis Market, by Application
8.1. Introduction
8.2. Cardiovascular
8.3. Diabetes
8.4. Immunological Disorders
8.5. Oncology
9. California Small-Molecule Apis Market10. Florida Small-Molecule Apis Market11. Illinois Small-Molecule Apis Market12. New York Small-Molecule Apis Market13. Ohio Small-Molecule Apis Market14. Pennsylvania Small-Molecule Apis Market15. Texas Small-Molecule Apis Market
16. Competitive Landscape
16.1. Fpnv Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, by Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Abbvie Inc.
17.2. Albemarle Corporation
17.3. Aspen Group
17.4. Aurobindo Pharma Limited
17.5. Bachem Holding Ag
17.6. Boehringer Ingelheim GmbH
17.7. Bristol-Myers Squibb
17.8. Cambrex Corporation by Permira Funds
17.9. Carlyle Group
17.10. Dr. Reddy's Laboratories Ltd.
17.11. F. Hoffmann-La Roche Ltd,
17.12. Gilead Sciences, Inc
17.13. GlaxoSmithKline plc
17.14. Janssen Global Services, LLC (Johnson & Johnson Inc.)
17.15. Johnson Matthey
17.16. Koninklijke Dsm N.V.
17.17. Lonza Group Ag
17.18. Novartis Ag
17.19. Pcas Sa
17.20. Pfizer Inc
17.21. Sanofi S.A.
17.22. Siegfried Ag
17.23. Sun Pharmaceutical Industries Ltd
17.24. Teva Pharmaceutical Industries Limited
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES SMALL-MOLECULE APIS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES SMALL-MOLECULE APIS MARKET DYNAMICS
FIGURE 8. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2027
FIGURE 11. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY CONTRACT MANUFACTURING, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY CONTRACT MANUFACTURING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY IN-HOUSE MANUFACTURING, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 16. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2027
FIGURE 18. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY BIOLOGICAL, 2019-2027 (USD MILLION)
FIGURE 19. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY BIOLOGICAL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 20. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY SYNTHETIC, 2019-2027 (USD MILLION)
FIGURE 21. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY SYNTHETIC, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 22. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 23. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2027
FIGURE 25. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2019-2027 (USD MILLION)
FIGURE 26. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY DIABETES, 2019-2027 (USD MILLION)
FIGURE 28. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY DIABETES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, 2019-2027 (USD MILLION)
FIGURE 30. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 31. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD MILLION)
FIGURE 32. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 33. CALIFORNIA SMALL-MOLECULE APIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 34. FLORIDA SMALL-MOLECULE APIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 35. ILLINOIS SMALL-MOLECULE APIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. NEW YORK SMALL-MOLECULE APIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. OHIO SMALL-MOLECULE APIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. PENNSYLVANIA SMALL-MOLECULE APIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. TEXAS SMALL-MOLECULE APIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. UNITED STATES SMALL-MOLECULE APIS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 41. UNITED STATES SMALL-MOLECULE APIS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 42. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES SMALL-MOLECULE APIS MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES SMALL-MOLECULE APIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY CONTRACT MANUFACTURING, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY BIOLOGICAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY SYNTHETIC, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY DIABETES, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 16. CALIFORNIA SMALL-MOLECULE APIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 17. CALIFORNIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2019-2027 (USD MILLION)
TABLE 18. CALIFORNIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 19. CALIFORNIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 20. FLORIDA SMALL-MOLECULE APIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 21. FLORIDA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2019-2027 (USD MILLION)
TABLE 22. FLORIDA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 23. FLORIDA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 24. ILLINOIS SMALL-MOLECULE APIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 25. ILLINOIS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2019-2027 (USD MILLION)
TABLE 26. ILLINOIS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 27. ILLINOIS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 28. NEW YORK SMALL-MOLECULE APIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 29. NEW YORK SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2019-2027 (USD MILLION)
TABLE 30. NEW YORK SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 31. NEW YORK SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 32. OHIO SMALL-MOLECULE APIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 33. OHIO SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2019-2027 (USD MILLION)
TABLE 34. OHIO SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 35. OHIO SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 36. PENNSYLVANIA SMALL-MOLECULE APIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 37. PENNSYLVANIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2019-2027 (USD MILLION)
TABLE 38. PENNSYLVANIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 39. PENNSYLVANIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 40. TEXAS SMALL-MOLECULE APIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 41. TEXAS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2019-2027 (USD MILLION)
TABLE 42. TEXAS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 43. TEXAS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 44. UNITED STATES SMALL-MOLECULE APIS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 45. UNITED STATES SMALL-MOLECULE APIS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 46. UNITED STATES SMALL-MOLECULE APIS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 47. UNITED STATES SMALL-MOLECULE APIS MARKET RANKING
TABLE 48. UNITED STATES SMALL-MOLECULE APIS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 49. UNITED STATES SMALL-MOLECULE APIS MARKET MERGER & ACQUISITION
TABLE 50. UNITED STATES SMALL-MOLECULE APIS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 51. UNITED STATES SMALL-MOLECULE APIS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 52. UNITED STATES SMALL-MOLECULE APIS MARKET INVESTMENT & FUNDING
TABLE 53. UNITED STATES SMALL-MOLECULE APIS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 54. UNITED STATES SMALL-MOLECULE APIS MARKET: LICENSE & PRICING

Companies Mentioned

  • AbbVie Inc.
  • Albemarle Corporation
  • Aspen Group
  • Aurobindo Pharma Limited
  • Bachem Holding AG
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb
  • Cambrex Corporation by Permira funds
  • Carlyle Group
  • Dr. Reddy’s Laboratories Ltd.
  • F. Hoffmann-La Roche Ltd,
  • Gilead Sciences, Inc
  • GlaxoSmithKline PLC
  • Janssen Global Services, LLC (Johnson & Johnson Inc.)
  • Johnson Matthey
  • Koninklijke DSM N.V.
  • Lonza Group AG
  • Novartis AG
  • PCAS SA
  • Pfizer Inc
  • Sanofi S.A.
  • Siegfried AG
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Limited

Methodology

Loading
LOADING...